CA2812898C - Cyclohexane derivative compound - Google Patents

Cyclohexane derivative compound Download PDF

Info

Publication number
CA2812898C
CA2812898C CA2812898A CA2812898A CA2812898C CA 2812898 C CA2812898 C CA 2812898C CA 2812898 A CA2812898 A CA 2812898A CA 2812898 A CA2812898 A CA 2812898A CA 2812898 C CA2812898 C CA 2812898C
Authority
CA
Canada
Prior art keywords
group
methyl
trans
acceptable salt
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2812898A
Other languages
English (en)
French (fr)
Other versions
CA2812898A1 (en
Inventor
Narihiro Toda
Rieko Takano
Takeshi Shida
Takahiro Katagiri
Mitsuhiro Iwamoto
Shinji Ashida
Mami Yamazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Co Ltd
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of CA2812898A1 publication Critical patent/CA2812898A1/en
Application granted granted Critical
Publication of CA2812898C publication Critical patent/CA2812898C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255Tartaric acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • C07D213/6432-Phenoxypyridines; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA2812898A 2010-09-27 2011-09-26 Cyclohexane derivative compound Expired - Fee Related CA2812898C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010-215403 2010-09-27
JP2010215403 2010-09-27
PCT/JP2011/071830 WO2012043445A1 (ja) 2010-09-27 2011-09-26 シクロヘキサン誘導体化合物

Publications (2)

Publication Number Publication Date
CA2812898A1 CA2812898A1 (en) 2012-04-05
CA2812898C true CA2812898C (en) 2015-11-17

Family

ID=45892891

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2812898A Expired - Fee Related CA2812898C (en) 2010-09-27 2011-09-26 Cyclohexane derivative compound

Country Status (29)

Country Link
US (3) US8710060B2 (OSRAM)
EP (1) EP2623492B1 (OSRAM)
JP (1) JP5753179B2 (OSRAM)
KR (1) KR20130109124A (OSRAM)
CN (1) CN103108866B (OSRAM)
AU (1) AU2011309212B2 (OSRAM)
BR (1) BR112013007145A2 (OSRAM)
CA (1) CA2812898C (OSRAM)
CO (1) CO6690804A2 (OSRAM)
CY (1) CY1115450T1 (OSRAM)
DK (1) DK2623492T3 (OSRAM)
ES (1) ES2478518T3 (OSRAM)
HR (1) HRP20140720T1 (OSRAM)
IL (1) IL225440A (OSRAM)
IN (1) IN2013MN00506A (OSRAM)
MX (1) MX2013003219A (OSRAM)
MY (1) MY157542A (OSRAM)
NZ (1) NZ609596A (OSRAM)
PH (1) PH12013500583A1 (OSRAM)
PL (1) PL2623492T3 (OSRAM)
PT (1) PT2623492E (OSRAM)
RS (1) RS53447B (OSRAM)
RU (1) RU2013119603A (OSRAM)
SG (1) SG188415A1 (OSRAM)
SI (1) SI2623492T1 (OSRAM)
SM (1) SMT201400109B (OSRAM)
TW (1) TWI501953B (OSRAM)
WO (1) WO2012043445A1 (OSRAM)
ZA (1) ZA201301652B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ609596A (en) * 2010-09-27 2013-12-20 Daiichi Sankyo Co Ltd Cyclohexane derivative compound
US10352962B2 (en) 2016-12-29 2019-07-16 BioMech Sensor LLC Systems and methods for real-time data quantification, acquisition, analysis and feedback
US11318350B2 (en) 2016-12-29 2022-05-03 BioMech Sensor LLC Systems and methods for real-time data quantification, acquisition, analysis, and feedback
US10973439B2 (en) 2016-12-29 2021-04-13 BioMech Sensor LLC Systems and methods for real-time data quantification, acquisition, analysis, and feedback
US9773330B1 (en) 2016-12-29 2017-09-26 BioMech Sensor LLC Systems and methods for real-time data quantification, acquisition, analysis, and feedback

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6511980B2 (en) * 2000-05-05 2003-01-28 Ortho Mcneil Pharmaceutical, Inc. Substituted diamine derivatives useful as motilin antagonists
US7262195B2 (en) 2003-09-17 2007-08-28 Bristol-Myers Squibb Company Compounds useful as motilin agonists and method
GB0611907D0 (en) 2006-06-15 2006-07-26 Glaxo Group Ltd Compounds
GB0515381D0 (en) * 2005-07-26 2005-08-31 Glaxo Group Ltd Compounds
GB0612844D0 (en) * 2006-06-28 2006-08-09 Glaxo Group Ltd Compounds
US7700599B2 (en) * 2006-06-28 2010-04-20 Glaxo Group Limited Gpr38 Receptor Agonists
GB0723317D0 (en) 2007-11-28 2008-01-09 Glaxo Group Ltd Compounds
NZ609596A (en) * 2010-09-27 2013-12-20 Daiichi Sankyo Co Ltd Cyclohexane derivative compound

Also Published As

Publication number Publication date
PT2623492E (pt) 2014-08-29
EP2623492A4 (en) 2013-09-25
CO6690804A2 (es) 2013-06-17
SMT201400109B (it) 2014-09-08
MX2013003219A (es) 2013-06-18
TWI501953B (zh) 2015-10-01
EP2623492A1 (en) 2013-08-07
IN2013MN00506A (OSRAM) 2015-05-29
US20140221392A1 (en) 2014-08-07
US8710060B2 (en) 2014-04-29
JP5753179B2 (ja) 2015-07-22
EP2623492B1 (en) 2014-05-14
CY1115450T1 (el) 2017-01-04
ES2478518T3 (es) 2014-07-22
HRP20140720T1 (hr) 2014-08-29
SG188415A1 (en) 2013-04-30
TW201217342A (en) 2012-05-01
CN103108866B (zh) 2015-09-09
AU2011309212A1 (en) 2013-03-21
CA2812898A1 (en) 2012-04-05
RU2013119603A (ru) 2014-11-10
PL2623492T3 (pl) 2014-09-30
ZA201301652B (en) 2014-04-30
RS53447B (en) 2014-12-31
WO2012043445A1 (ja) 2012-04-05
PH12013500583A1 (en) 2013-05-20
IL225440A0 (en) 2013-06-27
US9051255B2 (en) 2015-06-09
AU2011309212B2 (en) 2014-06-19
MY157542A (en) 2016-06-15
KR20130109124A (ko) 2013-10-07
CN103108866A (zh) 2013-05-15
IL225440A (en) 2015-11-30
DK2623492T3 (da) 2014-08-11
BR112013007145A2 (pt) 2016-06-14
SI2623492T1 (sl) 2014-09-30
JPWO2012043445A1 (ja) 2014-02-06
US20130289048A1 (en) 2013-10-31
US20140221391A1 (en) 2014-08-07
NZ609596A (en) 2013-12-20
HK1185081A1 (en) 2014-02-07

Similar Documents

Publication Publication Date Title
JP5425772B2 (ja) カルボン酸化合物
CA2812898C (en) Cyclohexane derivative compound
KR20100132073A (ko) Pai―1 저해제
JP2009544696A (ja) バニロイド受容体アンタゴニストとしての、新規化合物、その異性体またはその薬学的に許容される塩;並びにそれを含む医薬組成物
WO2020242943A1 (en) Gpr40 agonists
AU2019298306B2 (en) Novel compounds for controlling arthropods
EP2602248A1 (en) Novel pyrrole compounds
DE69408580T2 (de) 2-amino-1,2,3,4-tetrahydronaphthalenderivate mit cardiovaskulärer wirkung
DE10100772A1 (de) Ether- und Amidverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Antidiabetika
KR20140009125A (ko) 당뇨병 및 이상지질혈증 치료 방법 및 조성물
RU2619105C2 (ru) Фенильное производное
JPWO2013021949A1 (ja) 置換4,4−ジフルオロ−2−ブテン−1−オン化合物及び置換イソキサゾリン化合物の製造方法
AU2014312756A1 (en) Novel aromatic compound and use thereof
CA3147498A1 (en) Pyrazole derivatives for controlling arthropods
WO2015137407A1 (ja) ヘテロアリールカルボン酸エステル誘導体の製造方法、その製造中間体及び結晶
HK1185081B (en) Cyclohexane derivative compound
JP2011148774A (ja) カルボン酸化合物を含有する医薬
CN120208936A (zh) 含硫芳香类丙酸衍生物、其制备方法、药物组合物及应用
JP2012067054A (ja) スルホンアミド誘導体化合物

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130327

MKLA Lapsed

Effective date: 20180926